Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03134612Phase 2Completed
Phase 2, randomised, double-blind trial of ondansetron in pain (2 arms), sponsored by Universitas Indonesia. Primary endpoint: The Degree of pain due to Propofol Injection at Day 1. Started Jul 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03134612.